Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs, today announced the dosing of the first patient in the Phase 2 trial of YA-101 for Multiple ...

Researchers at Penn Vet and the University of Padova identified a novel variant connected to progressive retinal atrophy ...

The journey of recovery and success requires resilience, adaptability, and perseverance, as seen in astronauts and ...

Frederic L.W.V.J. Schaper, MD, PhD , director of Epilepsy Network Mapping at the Center for Brain Circuit Therapeutics at ...

Frederic L.W.V.J. Schaper, MD, PhD, director of Epilepsy Network Mapping at the Center for Brain Circuit Therapeutics at Brigham and Women’s Hospital and an instructor of neurology at Harvard Medical ...

In collaboration with a foundation that breeds service dogs for the visually impaired, researchers at the School of ...

MYOS CORP Secures 9th U.S. Patent, "Methods for Alleviating, Inhibiting or Reversing Muscle Disuse Atrophy in Mammals." "This is a major milestone for MYOS," said Joseph Mannello, CEO of MYOS CORP.